Decreased Lamina Propria Effector Cell Responsiveness to Interleukin-10 in Ileal Crohn's Disease
Authors:
- Kathleen VanstraelenKVKathleen Vanstraelen
- Zhanju LiuZLZhanju Liu
- Freddy PenninckxFPFreddy Penninckx
- Karel GeboesKGKarel Geboes
- Paul RutgeertsPRPaul Rutgeerts
- Jan CeuppensJCJan Ceuppens
- 31 January 2002
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 102 (1) , 68-76
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Phenotypical and functional characterization of the antigen presenting cell in Crohn's diseaseGastroenterology, 2000
- SYSTEMIC ADMINISTRATION OF CELLULAR INTERLEUKIN-10 CAN EXACERBATE CARDIAC ALLOGRAFT REJECTION IN MICE1,2Transplantation, 1996
- Enterocolitis and colon cancer in interleukin-10-deficient mice are associated with aberrant cytokine production and CD4(+) TH1-like responses.Journal of Clinical Investigation, 1996
- Interleukin‐10 differentially regulates B7‐1 (CD80) and B7‐2 (CD86) expression on human peripheral blood dendritic cellsEuropean Journal of Immunology, 1995
- Non-cytotoxic, IL-4, IL-5, IL-10 producing CD8+ T cells: their activation and effector functionsCurrent Opinion in Immunology, 1994
- Interleukin 10 (IL-10) upregulates IL-1 receptor antagonist production from lipopolysaccharide-stimulated human polymorphonuclear leukocytes by delaying mRNA degradation.Journal of Experimental Medicine, 1994
- Interleukin-10Annual Review of Immunology, 1993
- Interferon gamma inhibits interleukin 10 production by monocytes.Journal of Experimental Medicine, 1993
- Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes.Journal of Experimental Medicine, 1991
- Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.Journal of Experimental Medicine, 1991